Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 4
1(100.0%)
1Total
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06433518Recruiting

BEst Size for Ovulation Triggering in Poseidon 4 Patients (BEST 4 Study)

Role: lead

NCT07348757Recruiting

rFSH vs rFSH+rLH in Dydrogesterone-Based Progestin Protocol: A Prospective Study

Role: lead

NCT03948022Phase 4Completed

Luteal Support in Frozen-Thawed Embryo Transfer Cycles

Role: lead

NCT03831542Completed

Effect of Follicular Flushing in Patients With Mono-follicular Growth Undergoing In Vitro Fertilization

Role: lead

All 4 trials loaded